Talks in this Session:
- Liquid Biopsy -- From Discovery to Clinical Implementation
- Maximizing Metastasis Insights: Using an Integrated Workflow Approach to Achieve Efficient CTC Enrichment with Targeted Enumeration for Versatile Downstream Applications
- A Development and Analysis Pipeline for MicroRNA Biomarker Signatures in Molecular Diagnostics Based on Circulating EVs
- Comparison of Two Digital PCR Systems for the Analysis of Liquid Biopsy Samples of Patients Affected by Lung and Colorectal Cancer
- Performance Evaluation of RNA Purification Kits and Blood Collection Tubes in the Extracellular RNA Quality Control (exRNAQC) Study
- HepatomiR® - MicroRNA Biomarkers of Liver Function: from Discovery to Implementation as a Diagnostic Test to Support Management of Liver Cancer Patients
- New Perspectives for Liquid Profiling of Circulating Nucleic Acids in Clinical Diagnostics
- Two-Tailed PCR for Precision Diagnostics
- Liquid Biopsies: Optimization and Sample Quality Controls for ctDNA Measurements
- Tumour-guided Personalised Sequencing Assays For ctDNA Detection
- Novel NGS-based Proteomics Revolutionizes Biomarker Identification in Liquid Biopsies
- Use of Synthetic Reference Sequence Spike-In Controls to Increase Reliability of NGS Testing for Actionable Mutations in Circulating Tumor DNA
- Clinical Applicability of Circulating Nucleic Acids
- Biological, Structural and Functional Aspects of Circulating Nucleic Acids
| Back to GQ2023 overview page |
|---|
